Health systems are introducing high-risk breast programs to help high-risk patients access the preventive care they need to manage risk of cancer.
There are many clear benefits to building a genetics program focused on identifying and treating patients with a high risk of a cancer diagnosis.
At the 10th Annual Clinical Cancer Genetics & Genomics Conference Haibo Lu and Matt Valin presented the challenges of high-risk cancer program design.
The CancerIQ product suite is an end-to-end solution, genetic history data gathering to supporting the management of high-risk care plans.
CancerIQ joined leading experts in breast health at the National Consortium of Breast Centers’ 31st Annual Interdisciplinary Breast Center...
As the nation honors Black History Month and National Cancer Prevention Month, experts are calling attention to disparities in screening access and...
Millions of women with a family history of breast or ovarian cancer have yet to undergo genetic testing despite lifetime risk being 7x higher than...
At HIMSS21, AHEAD Medical Director Candace Westgate, DO, explained how technology helped Adventist Health bring genomics to patients systemwide.
NCBC 2021: Breast centers expedited the adoption of virtual care to better serve high-risk patients missing appointments due to COVID-19.
Community centers lose revenue potential from patient leakage, up to $650,000, on average, per patient. But what if there were a way to plug those...